The group's principal activity is to provide software for systems biology, drug discovery, and drug development. The group's products include DataSpeaks Interactions®. Industries served by the group include pharmaceutical, health care, economies and capital markets, advancing responsible agency, and reinvigorating machine learning and artificial intelligence. The group operates from the United States.
